A 3-D printed model of the patient’s skull provided a vital road map to help University of Michigan doctors remove a tumor lodged deep in a teenager’s skull.

Learn the risk factors for heart disease by reading these simple things to measure. These tests will help you to discover your risk factors for heart disease.

TAVR changed the landscape for high-risk patients in need of new aortic heart valves. Now, new data supports the viability of TAVR out to three years.

Four kids in a Michigan town each battled severe illness at U-M’s Mott Children’s Hospital. Now, they’re all in the same 1st grade class. See their stories.

A University of Michigan Medical School study suggests that mind-body techniques are effective for managing PTSD in veterans in as little as four months.

Research from the University of Michigan Hepatology Program reminds physicians that drugs their patients commonly use may cause liver injury or failure.

Researchers at the University of Michigan published a study that could help many bipolar patients, and their care teams, stay the course on treatment.

Family genetic counselors can help make sense of a child's cancer diagnosis. Learn how genetic counseling can help patients identify risks and plan treatment.

Lori knew she had a congenital bicuspid aortic valve, but it never troubled her. When an ultrasound revealed an aneurysm, she looked to University of Michigan.

A doctor from the University of Michigan Health System has developed a way to visualize stored insulin in the pancreas of a living creature.

After a colorectal cancer patient finishes treatment, primary care doctors are being called to play a key role in their recovery and overall continued heath.

The first nationwide academic study of physician disciplinary actions and malpractice claims rates shows a lack of standardization across the country.

New medical research from the University of Michigan explores how a patient’s own immune system might help determine effective treatment options for cancer.

The FDA may reclassify electroconvulsive therapy devices from class III to class II. The FDA is accepting public comments on the change until March 28.

Researchers at the University of Michigan Medical School made the medical discovery that ancient viruses that infected our ancestors still remain in our genes.